Dealmaking Quarterly Statistics, Q2 2021
A Look At M&A And Alliance Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, April-June 2021
Executive Summary
During Q2, biopharma merger and acquisition value reached $34.7bn and drew in $33bn in potential deal value from alliances. Device company M&A values reached $2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $4.4bn.